Breaking point: the genesis and impact of structural variation in tumours. (2018)
Attributed to:
Precision medicine and the mutational landscape of high grade serous ovarian cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/f1000research.16079.1
PubMed Identifier: 30519450
Publication URI: http://europepmc.org/abstract/MED/30519450
Type: Journal Article/Review
Volume: 7
Parent Publication: F1000Research
ISSN: 2046-1402